<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-76040</identifier>
<setSpec>0213-4853</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Migraine with aura and patient foramen ovale. A different clinical entity?</dc:title>
<dc:description xml:lang="en">Introduction. This work has aimed to evaluate theprevalence of patent foramen ovale in subjects with migrainewith aura by transcranial contrast doppler and todescribe the clinical and risk profile of these patients.Method. We performed a transcranial contrast dopplerin 94 consecutive out-patients with migraine withaura (MWA) in a neurology outpatient clinic. They weredivided into two groups according to the presence of patentforamen ovale: MWA_RLsh (with right-to-leftshunt) and MWA_RLNsh (without right-to-left shunt).Differences between the groups were analyzed accordingto endpoints of age, gender, clinical severity, aura typeand attacks frequency, comorbility, cardiovascular riskfactors (CVRFs), neuroimaging findings, severity ofshunt and treatment.Results. n=94; MWA_RLsh: 47 (54%). MWA_RLNsh:40 (46%). Age: 33.13; standard desviation (SD): 10.8 vs33.496; SD: 11.2; p=0.728. Female: 66 vs 72.5%; p=0.511.Visual aura: 73.9% vs 78.9%; p=0.921. There were no significantdifferences in regards to the risk factors studied orto the comorbid diseases that are associated to migraine.The patients with patent foramen ovale have an odds ratio(OR) of ischemic stroke: 1.189 (95% confidence interval[CI]: 0.226 to 6.248; p=0.840), OR for subclinical brain lesionsin cranial magnetic resonance imaging (MRI): 0.589(95% CI: 0.193 to 1.799; p=0.35) and OR for combinedprevious ischemic stroke and subclinical brain lesions:0.745 (95% CI: 0.261 to 2.129; p=0.58). Migraine attackfrequency &gt;1 per month: 27.9 vs 36.4; p=0.464. Need forprophylaxis therapy: 44.7 vs 57.7%; p=0.284.Conclusions. Both groups are similar regarding their57 clinical profile. We did not find a greater prevalence of stroke or silent brain lesions in the group with positiveshunt (AU)</dc:description>
<dc:creator>Caballero, M</dc:creator>
<dc:creator>Casado Naranjo, I</dc:creator>
<dc:creator>Calle, M</dc:creator>
<dc:creator>Gómez, M</dc:creator>
<dc:creator>Tena Mora, D</dc:creator>
<dc:creator>Portilla, J. C</dc:creator>
<dc:creator>Ramirez Moreno, J. M</dc:creator>
<dc:creator>Falcón, A</dc:creator>
<dc:creator>Serrano, A</dc:creator>
<dc:creator>Ojalvo, M. J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. Este trabajo evalúa la prevalencia de foramenoval permeable en pacientes con migraña con aura medianteDoppler transcraneal con contraste y describe el perfilclínico y de riesgo según la presencia de shunt (derivación).Método. Se efectua Doppler transcraneal con contrastey estudio de resonancia magnética cerebral a 94 pacientesconsecutivos diagnosticados de migraña con aura en unaconsulta de neurología. Se dicotomizaron en dos grupos segúnla presencia de foramen oval permeable. Se analizaronlas diferencias entre grupos según las variables: edad, sexo,gravedad clínica, tipología y frecuencia de aura, antecedentescomórbidos, factores de riesgo cardiovascular, hallazgosde neuroimagen, grado de shunt y tratamiento.Resultados. n=94. Shunt presente: 47 (54 %). No shunt:40 (46 %). Edad: 33,13; desviación estándar (DE): 10,8 frentea 33,496; DE: 11,2; p=0,728. Sexo femenino: 66 frente a72,5 %; p=0,511. Aura visual: 73,9 frente a 78,9 %; p=0,921.No hay diferencias significativas con respecto a los factoresde riesgo estudiados ni tampoco con respecto a las enfermedadescomórbidas que se asocian a la migraña. Los pacientescon foramen oval permeable tienen una odds ratio(OR) de ictus isquémico: 1,189 (IC 95 %: 0,226 a 6,248;p=0,840); OR LCS: 0,589 (intervalo de confianza [IC] del 95%:0,193 a 1,799; p=0,35) y OR agrupación ictus y lesiones cerebralessilentes (LCS): 0,745 (IC 95%: 0,261 a 2,129; p=058).Frecuencia mayor a una crisis/mes: 27,9 frente al 36,4%;p=0,464. Necesidad de tratamiento profiláctico: 44,7 frenteal 57,7 %; p=0,284.Conclusiones. Ambos grupos son similares en cuanto alperfil clínico. No encontramos una mayor prevalencia de ictuso lesiones cerebrales silentes en el grupo con shunt positivo (AU)</dc:description>
<dc:source>Neurologia;23(8): 503-510, oct. 2008. tab, graf</dc:source>
<dc:identifier>ibc-76040</dc:identifier>
<dc:title xml:lang="es">Migraña con aura y foramen oval permeable. ¿Una entidad clínica diferente?</dc:title>
<dc:subject>^d331</dc:subject>
<dc:subject>^d52605^s22012</dc:subject>
<dc:subject>^d23405</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d52605^s29166</dc:subject>
<dc:subject>^d30991^s22074</dc:subject>
<dc:subject>^d34268^s29166</dc:subject>
<dc:subject>^d34268^s22027</dc:subject>
<dc:subject>^d34268^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200810</dc:date>
</metadata>
</record>
</ibecs-document>
